Attached files

file filename
8-K - FORM 8-K - WebMD Health Corp.d531785d8k.htm
EX-99.4 - EX-99.4 - WebMD Health Corp.d531785dex994.htm
EX-99.1 - EX-99.1 - WebMD Health Corp.d531785dex991.htm
EX-99.3 - EX-99.3 - WebMD Health Corp.d531785dex993.htm

Exhibit 99.2

WEBMD HEALTH CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data, unaudited)

 

     Three Months Ended
March 31,
 
     2013     2012  

Revenue

   $ 112,762      $ 106,947   

Cost of operations

     46,943        53,471   

Sales and marketing

     30,933        30,103   

General and administrative

     23,534        29,022   

Depreciation and amortization

     6,853        6,930   

Interest income

     21        11   

Interest expense

     5,832        5,836   

Gain on investments

     —          8,074   

Other expense

     —          1,200   
  

 

 

   

 

 

 

Loss before income tax provision (benefit)

     (1,312     (11,530

Income tax provision (benefit)

     226        (3,753
  

 

 

   

 

 

 

Net loss

   $ (1,538   $ (7,777
  

 

 

   

 

 

 
    

Net loss per common share - Basic and Diluted

   $ (0.03   $ (0.14
  

 

 

   

 

 

 
    

Weighted-average shares outstanding - Basic and Diluted

     49,007        55,769   
  

 

 

   

 

 

 


WEBMD HEALTH CORP.

CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION

(In thousands, unaudited)

 

     Three Months Ended
March 31,
 
     2013     2012  

Revenue

    

Public portal advertising and sponsorship

   $ 93,438      $ 87,776   

Private portal services

     19,324        19,171   
  

 

 

   

 

 

 
   $ 112,762      $ 106,947   
  

 

 

   

 

 

 
    

Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”) (a)

   $ 21,289      $ 11,251   

Interest, taxes, non-cash and other items (b)

    

Interest income

     21        11   

Interest expense

     (5,832     (5,836

Income tax (provision) benefit

     (226     3,753   

Depreciation and amortization

     (6,853     (6,930

Non-cash stock-based compensation

     (9,937     (16,900

Gain on investments

     —          8,074   

Other expense

     —          (1,200
  

 

 

   

 

 

 

Net loss

   $ (1,538   $ (7,777
  

 

 

   

 

 

 

 

(a) See Annex A-Explanation of Non-GAAP Financial Measures.
(b) Reconciliation of Adjusted EBITDA to net loss.


WEBMD HEALTH CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

 

     March 31, 2013      December 31, 2012  
     (unaudited)         

Assets

     

Cash and cash equivalents

   $ 999,221       $ 991,835   

Accounts receivable, net

     101,813         106,622   

Prepaid expenses and other current assets

     14,999         13,882   

Deferred tax assets

     10,339         10,328   
  

 

 

    

 

 

 

Total current assets

     1,126,372         1,122,667   

Property and equipment, net

     62,808         66,604   

Goodwill

     202,104         202,104   

Intangible assets, net

     15,538         16,105   

Deferred tax assets

     55,436         56,039   

Other assets

     25,260         27,106   
  

 

 

    

 

 

 

Total Assets

   $ 1,487,518       $ 1,490,625   
  

 

 

    

 

 

 
     

Liabilities and Stockholders’ Equity

     

Accrued expenses

   $ 49,107       $ 64,256   

Deferred revenue

     97,220         92,176   

Liabilities of discontinued operations

     1,506         1,506   
  

 

 

    

 

 

 

Total current liabilities

     147,833         157,938   

2.25% convertible notes due 2016

     400,000         400,000   

2.50% convertible notes due 2018

     400,000         400,000   

Other long-term liabilities

     22,742         22,698   

Stockholders’ equity

     516,943         509,989   
  

 

 

    

 

 

 

Total Liabilities and Stockholders’ Equity

   $ 1,487,518       $ 1,490,625   
  

 

 

    

 

 

 


WEBMD HEALTH CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands, unaudited)

 

     Three Months Ended
March 31,
 
     2013     2012  

Cash flows from operating activities:

    

Net loss

   $ (1,538   $ (7,777

Adjustments to reconcile net loss to net cash provided by operating activities:

    

Depreciation and amortization

     6,853        6,930   

Non-cash interest, net

     1,082        1,082   

Non-cash stock-based compensation

     9,937        16,900   

Deferred income taxes

     (99     (3,971

Gain on investments

     —          (8,074

Changes in operating assets and liabilities:

    

Accounts receivable

     4,809        23,890   

Prepaid expenses and other, net

     (193     (4,023

Accrued expenses and other long-term liabilities

     (14,850     (11,694

Deferred revenue

     5,044        2,266   
  

 

 

   

 

 

 

Net cash provided by operating activities

     11,045        15,529   

Cash flows from investing activities:

    

Proceeds received from ARS option

     —          9,269   

Purchases of property and equipment

     (2,876     (3,377
  

 

 

   

 

 

 

Net cash (used in) provided by investing activities

     (2,876     5,892   

Cash flows from financing activities:

    

Proceeds from exercise of stock options

     672        754   

Cash used for withholding taxes due on stock-based awards

     (174     (911

Purchases of treasury stock

     (1,281     (415
  

 

 

   

 

 

 

Net cash used in financing activities

     (783     (572
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

     7,386        20,849   

Cash and cash equivalents at beginning of period

     991,835        1,121,217   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 999,221      $ 1,142,066